Literature DB >> 31978499

Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis.

Jinzhao Gao1, Jijun Teng1, Zongchao Liu1, Min Cai1, Anmu Xie2.   

Abstract

The relationships between vitamin D receptor (VDR) gene polymorphisms, particularly ApaI, BsmI, FokI, and TaqI, and Parkinson's disease (PD) has received increasing attention in the research community. However, as the results yielded by this increased research have hitherto conflicted, we performed an updated meta-analysis of reports on the relationships between VDR polymorphisms and PD published before October 2019 that we collected from the PUBMED, EMBASE, EBSCO, China National Knowledge Infrastructure (CNKI), and Wanfang databases. The ten articles that met our screening criteria included 2782 patients and 3194 healthy controls. All the data that we received were analyzed with Stata 12.0 statistical software. The odds ratio (OR) and 95 % confidence intervals (CIs) were used to determine the relationship between VDR gene diversity and PD. While we did not find a significant correlation between the ApaI, BsmI, and TaqI polymorphisms and the risk of PD in any of the considered genetic models, we found a clear association between the FokI polymorphism and susceptibility to PD (C vs. T: OR = 1.246, 95 % CI: 1.101-1.411, P = 0; CC vs. TT: OR = 1.630, 95 % CI: 1.243-2.139, P = 0; CT vs. TT: OR = 1.382, 95 % CI: 1.059-1.804, P = 0.017; CC + CT vs. TT: OR = 1.491, 95 % CI: 1.159-1.919,P = 0.002; CC vs. CT + TT: OR = 1.261, 95 % CI: 1.062-1.496, P = 0.008). Our subgroup analysis performed according to ethnicity revealed that FokI increased the risk of PD in Asian populations (C vs. T: OR = 1.261, 95 % CI: 1.080-1.472, P = 0.003; CC vs. TT: OR = 1.664, 95 % CI: 1.189-2.330, P = 0.003; CT vs.TT: OR = 1.387, 95 % CI: 1.000-1.925, P = 0.05; CC + CT vs. TT: OR = 1.497, 95 % CI: 1.098-2.042, P = 0.011; CC vs. CT + TT: OR = 1.285, 95 % CI: 1.036-1.593, P = 0.022). Overall, the gene polymorphism of FokI only increases the risk of PD among Asian populations. Given the limited sample size of this study, the findings should be carefully explained.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Meta-analysis; Parkinson's disease; Polymorphisms; Vitamin D receptor

Mesh:

Substances:

Year:  2020        PMID: 31978499     DOI: 10.1016/j.neulet.2020.134778

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Vitamin D Status and Parkinson's Disease.

Authors:  Michela Barichella; Federica Garrì; Serena Caronni; Carlotta Bolliri; Luciano Zocchi; Maria Carmela Macchione; Valentina Ferri; Daniela Calandrella; Gianni Pezzoli
Journal:  Brain Sci       Date:  2022-06-16

2.  Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor.

Authors:  José A G Agúndez; Elena García-Martín; Hortensia Alonso-Navarro; Christopher Rodríguez; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Julián Benito-León; Tomás López-Alburquerque; Félix Javier Jiménez-Jiménez
Journal:  Mol Neurobiol       Date:  2022-03-24       Impact factor: 5.590

3.  Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson's Disease and Dopaminergic Treatment Adverse Events.

Authors:  Sara Redenšek; Tilen Kristanc; Tanja Blagus; Maja Trošt; Vita Dolžan
Journal:  Front Aging Neurosci       Date:  2022-04-19       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.